Clinical Trial Update: A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results for Modakafusp Alfa in adults with relapsed/refractory multiple myeloma. The Phase 1/2 study has been terminated and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Modakafusp Alfa (modakafusp alfa)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D LLC | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-10-20